the acquisition. He said, “The acquisition of MBC aligns with GBG’s long standing core focus on Women’s Health which dates back to its inception in 1998. Adding MBC to GBG’s existing portfolio allows us to broaden our services. We are confident that together we will create a more powerful platform from which to deliver proactive breast health services with an emphasis placed on wellness, prevention, and early detection.”
Ben Bandaru, Ph.D, Director of Corporate Development for GBG spoke about the company’s mission. He said, “Our aspiration for Genesis Health™, a newly created division of GBG, is nothing less than building a world-class medical research center exclusively for women’s health. Acquisition of MBC is a perfect start for that journey. The ongoing uncertainty due to the Pandemic highlights the need for small to midsize medical practitioners to focus on their core business strengths, overcome infrastructure and service gaps through viable partnerships, and build scale to respond to new challenges.”
Nancy Elliott, MD, FACS, Founder and Director of MBC expressed delight over the new partnership. She said, “At Montclair Breast Center we are passionate about our mission to eradicate breast cancer as a life-threatening disease in women. Our partnership with Genesis Biotechnology Group will enable us to expand our innovative, groundbreaking paradigm of proactive, multidisciplinary breast care, thereby raising the bar for women’s health.” For the transaction with MBC, Bill Adam and WA Healthcare Associates, LLC acted as advisors to GBG.
